QYResearch: The global sale of Minocycline Hydrochloride is 8372 Kg in 2016

QYResearch focus on Market Survey and Research

qyresearchglobal.com

QYResearch

Contact Beijing Hengzhou Bozhi International Information Consulting Web: qyresearchglobal.com | qyresearcheurope.com |

qyresearch.com | qyresearch.com/english | qyresearchjapan.com TEL:+86-13660489419, Office:+86-2086655165 Marketing: sales@qyresearch.com Media: press@qyresearch.com

Facebook：@QYResearchOfficial, Twitter: @QYResearch_ Wechat Official Account: QYResearch, Weibo: 恒州博智

qyresearchglobal.com

QYResearch Minocycline Hydrochloride, also called minocycline HCL, is a broad-spectrum tetracycline antibiotic, and has a broader spectrum than the other members of the group. It is a bacteriostatic antibiotic, classified as a long-acting type. As a result of its long half-life it generally has serum levels 2–4 times that of the simple water-soluble tetracyclines. The CAS Number is 13614-98-7.

qyresearchglobal.com

QYResearch The sales of Minocycline Hydrochloride mainly focuse on Europe, Japan, China and USA. The Europe occupies the largest share and it reaches about 36.23% in 2016. The other countries have to import from Europe. According to QYResearch, The Minocycline Hydrochloride consumption has big proportion of the import and export trade, the main consumption is in EU, USA and China and the USA and China have to import from Europe. The global sale of Minocycline Hydrochloride is 8372 Kg in 2016.

The Minocycline Hydrochloride product increased slowly in the past five years, with the GAGR of 4.2%. Even some manufacturers are to halt production; the main reason is the emergence of alternatives and variety of antibiotic medicines.

Because of the raw materials and downtown demand, the price of Minocycline Hydrochloride is decreasing in the past few years. And the Minocycline Hydrochloride is rigged market by the main manufacturers.

qyresearchglobal.com

QYResearch The Minocycline Hydrochloride price in China is lower than the Europe and USA, also the profit is low in China.

It will expect that the sales and the capacity will increase slowly in the future, and because of substitute goods, the product may be disappearing in the future. QYR recommended the new company do not engaged in the production of the product.

More: http://www.qyresearchglobal.com/goods-674692.html

qyresearchglobal.com